Source: http://farmaceutika.info/thallous-t1-201-chloride-injection
Timestamp: 2019-04-25 01:49:44+00:00

Document:
PARTICULARS TO APPEAR ON THE OUTER PACKAGING tin container 1.
Thallous (Tl201) Chloride Injection, 37 MBq/ml, solution for injection. 2.
Contains: Thallous (Tl201) Chloride 37 MBq/ml 3.
sodium chloride, water for injections. 4.
solution for injection 63 MBq in 1.7 ml at ART 85 MBq in 2.3 ml at ART 213 MBq in 5.8 ml at ART 370 MBq in 10.0 ml at ART 5.
For multi-dose use. Intravenous use. Read the package leaflet before use. 6.
Keep out of the sight and reach of children. 7.
EXP: After aseptic removal of the first aliquot the product is stable for 8 hours stored at 2°C-8°C.
Do not store above 25°C. 10. SPECIAL PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE Any unused product or waste material should be disposed of in accordance with local requirements. 11. NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER Mallinckrodr Medical B.V. Westerduinweg 3 1755 LE PETTEN the Netherlands 12. MARKETING AUTHORISATION NUMBER(S) 88/211/93-C 13. BATCH NUMBER Lot: 14. GENERAL CLASSIFICATION FOR SUPPLY Medicinal product subject to medicinal prescription. 15. INSTRUCTIONS ON USE 16. INFORMATION IN BRAILLE Nevyžaduje se – odůvodnění přijato.
MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS injection vial 1.
Thallous (Tl201) Chloride Injection, 37 MBq/ml, solution for injection Intravenous use. 2.
Thallous (Tl201) Chloride injection 63 MBq in 1.7 ml at ART 85 MBq in 2.3 ml at ART 213 MBq in 5.8 ml at ART 370 MBq in 10.0 ml at ART 6.

References: ART 85
 ART 213
 ART 370
 ART 5
 ART 85
 ART 213
 ART 370
 ART 6